BTG3 and interstitial lung disease: Of the patients with RP-ILD, 84.6% had positive ANA and 88.9% had elevated CYFRA211.which indicated positive ANA and elevated CYFRA21-1 levels may be useful markers for the development of RP-ILD; however, further prospective studies are needed to verify this.